These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
470 related items for PubMed ID: 11107180
1. MYCN amplification and 17q in neuroblastoma: evidence for structural association. O'Neill S, Ekstrom L, Lastowska M, Roberts P, Brodeur GM, Kees UR, Schwab M, Bown N. Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180 [Abstract] [Full Text] [Related]
2. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N. N Engl J Med; 1999 Jun 24; 340(25):1954-61. PubMed ID: 10379019 [Abstract] [Full Text] [Related]
3. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore. Yong MH, Hwang WS, Knight LA, Fung W, Chan MY, Seow WT, Chui CH. Singapore Med J; 2009 Nov 24; 50(11):1090-4. PubMed ID: 19960166 [Abstract] [Full Text] [Related]
4. Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Lastowska M, Roberts P, Pearson AD, Lewis I, Wolstenholme J, Bown N. Genes Chromosomes Cancer; 1997 Jul 24; 19(3):143-9. PubMed ID: 9218994 [Abstract] [Full Text] [Related]
5. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma. Spitz R, Hero B, Ernestus K, Berthold F. Clin Cancer Res; 2003 Oct 15; 9(13):4835-40. PubMed ID: 14581355 [Abstract] [Full Text] [Related]
6. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN. Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382 [Abstract] [Full Text] [Related]
7. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N. Genes Chromosomes Cancer; 1997 Mar 27; 18(3):162-9. PubMed ID: 9071568 [Abstract] [Full Text] [Related]
8. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Boecker W, Dockhorn-Dworniczak B. Med Pediatr Oncol; 2001 Jan 27; 36(1):11-3. PubMed ID: 11464859 [Abstract] [Full Text] [Related]
9. Regions syntenic to human 17q are gained in mouse and rat neuroblastoma. Łastowska M, Chung YJ, Cheng Ching N, Haber M, Norris MD, Kees UR, Pearson AD, Jackson MS. Genes Chromosomes Cancer; 2004 Jun 27; 40(2):158-63. PubMed ID: 15101050 [Abstract] [Full Text] [Related]
10. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD, U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol; 2001 Jan 27; 36(1):14-9. PubMed ID: 11464868 [Abstract] [Full Text] [Related]
11. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1. Spieker N, Beitsma M, Van Sluis P, Chan A, Caron H, Versteeg R. Genes Chromosomes Cancer; 2001 Jun 27; 31(2):172-81. PubMed ID: 11319804 [Abstract] [Full Text] [Related]
12. MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines. Kuzyk A, Booth S, Righolt C, Mathur S, Gartner J, Mai S. Genes Chromosomes Cancer; 2015 Oct 27; 54(10):616-28. PubMed ID: 26171843 [Abstract] [Full Text] [Related]
13. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma. Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, O'Meara A, Ryan E, Catchpoole D, Breatnach F. Cytogenet Genome Res; 2004 Oct 27; 106(1):49-54. PubMed ID: 15218241 [Abstract] [Full Text] [Related]
14. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping. Stark B, Jeison M, Bar-Am I, Glaser-Gabay L, Mardoukh J, Luria D, Feinmesser M, Goshen Y, Stein J, Abramov A, Zaizov R, Yaniv I. Genes Chromosomes Cancer; 2002 Jul 27; 34(3):313-24. PubMed ID: 12007192 [Abstract] [Full Text] [Related]
15. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F. Genes Chromosomes Cancer; 2002 Jul 27; 34(3):299-305. PubMed ID: 12007190 [Abstract] [Full Text] [Related]
16. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors. Valent A, Guillaud-Bataille M, Farra C, Lozach F, Spengler B, Terrier-Lacombe MJ, Valteau-Couanet D, Danglot G, Lenoir GM, Brison O, Bénard J, Bernheim A. Cancer Genet Cytogenet; 2004 Aug 27; 153(1):10-5. PubMed ID: 15325088 [Abstract] [Full Text] [Related]
17. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Leong PK, Thorner P, Yeger H, Ng K, Zhang Z, Squire J. Lab Invest; 1993 Jul 27; 69(1):43-50. PubMed ID: 8331897 [Abstract] [Full Text] [Related]
18. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration]. Schwab M. Klin Padiatr; 1990 Jul 27; 202(4):197-201. PubMed ID: 2203936 [Abstract] [Full Text] [Related]